Abbott completed enrollment for the TECTONIC CAD IVL IDE study, designed to evaluate the SonicForce Coronary IVL System as a vessel preparation option for CAD.
Public source
Publisher name
Public post
Enrollment is now complete for the TECTONIC CAD IVL IDE study! The study is designed to evaluate the SonicForce™ Coronary IVL System as a vessel preparation option for C…
Company
Abbott
- Industry
- Hospitals and Health Care
- Location
- Abbott Park, US
- Company size
- 10,001+ employees
About Abbott
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritional and branded generic medicines. Our 122,000 colleagues serve people in more than 160 countries. Connect with us at www.abbott.com, on Facebook at www.facebook.com/Abbott and www.facebook.com/AbbottCareers, on Instagram @AbbottGlobal, and on X @AbbottNews. We invite you to explore opportunities at Abbott, to see if your talents and career aspirations may fit with our openings. An equal opportunity employer, Abbott welcomes and encourages diversity in our workforce. Terms of Use: https://www.abbott.com/social-media-terms-of-use.html Privacy Policy: https://abbo.tt/privacy
See moreDiscover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
BIOTRONIK
BIOTRONIK announced that the Trinity Health Ann Arbor team completed their first BIO-LivIQ study implant.
Research & Knowledge
Shockwave Medical
Shockwave Medical published results from a real-world study of the ShockwaveReducer in UK hospitals over a 10-year period published by Drs. Ranil De Silva and Kevin Cheng at the Royal Brompton and Harefield hospitals and Imperial College London.
Research & Knowledge
Edwards Lifesciences
Edwards Lifesciences published a new study in the NEJM titled TRIC-I-HF reporting hard endpoint benefits for transcatheter tricuspid repair plus medical therapy versus medical therapy alone in severe TR patients at increased risk for future heart failure events.
Research & Knowledge
Philips
Philips published RECTIFY primary results showing electrophysiology consultations increased 76.9% and infectious disease consultations increased 49.2%
Research & Knowledge
atHeart Medical